GFAP and Alzheimer disease: Correlation analyses demonstrated negative associations between MoCA scores and plasma biomarker levels of p-tau181 (p < 0.001), p-tau217 (p = 0.024), and GFAP (p = 0.002) among AD patients (Table 2).